Adrián Ruiz-Villalba

Dr. Adrián Ruiz-Villalba

University of Málaga (Spain)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2021 in Life
Verified
Journal Article
Open access
PDF file
ARAdrián Ruiz-Villalba
Adrián Ruiz-Villalba
JRJan M Ruijter
Jan M Ruijter
Maurice J B van den HoffMaurice J B van den Hoff
Maurice J B van den Hoff
In the analysis of quantitative PCR (qPCR) data, the quantification cycle (Cq) indicates the position of the amplification curve with respect to the cycle axis. Because Cq is directly related to the starting concentration of the target, and the difference in Cq values is related to the starting concentration ratio, the only results of qPCR analysis reported are often Cq, ΔCq or ΔΔCq values. However, reporting of Cq values ignores the fact that Cq values may differ between runs and machines, and, therefore, cannot be compared between laboratories. Moreover, Cq values are highly dependent on the PCR efficiency, which differs between assays and may differ between samples. Interpreting reported Cq values, assuming a 100% efficient PCR, may lead to assumed gene expression ratios that are 100-fold off. This review describes how differences in quantification threshold setting, PCR efficiency, starting material, PCR artefacts, pipetting errors and sampling variation are at the origin of differences and variability in Cq values and discusses the limits to the interpretation of observed Cq values. These issues can be avoided by calculating efficiency-corrected starting concentrations per reaction. The reporting of gene expression ratios and fold difference between treatments can then easily be based on these starting concentrations.

12 May 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
EMErnesto Marín-Sedeño
Ernesto Marín-Sedeño
XMXabier Martínez de Morentin
Xabier Martínez de Morentin
JPJose M. Pérez-Pomares
Jose M. Pérez-Pomares
DGDavid Gomez-Cabrero
David Gomez-Cabrero
ARAdrián Ruiz-Villalba
Adrián Ruiz-Villalba
During the last decade, extensive efforts have been made to comprehend cardiac cell genetic and functional diversity. Such knowledge allows for the definition of the cardiac cellular interactome as a reasonable strategy to increase our understanding of the normal and pathologic heart. Previous experimental approaches including cell lineage tracing, flow cytometry, and bulk RNA-Seq have often tackled the analysis of cardiac cell diversity as based on the assumption that cell types can be identified by the expression of a single gene. More recently, however, the emergence of single-cell RNA-Seq technology has led us to explore the diversity of individual cells, enabling the cardiovascular research community to redefine cardiac cell subpopulations and identify relevant ones, and even novel cell types, through their cell-specific transcriptomic signatures in an unbiased manner. These findings are changing our understanding of cell composition and in consequence the identification of potential therapeutic targets for different cardiac diseases. In this review, we provide an overview of the continuously changing cardiac cellular landscape, traveling from the pre-single-cell RNA-Seq times to the single cell-RNA-Seq revolution, and discuss the utilities and limitations of this technology.

Verified
Journal Article
Open access
PDF file
PPPaul Palmquist-Gomes
Paul Palmquist-Gomes
EMErnesto Marín-Sedeño
Ernesto Marín-Sedeño
ARAdrián Ruiz-Villalba
Adrián Ruiz-Villalba
GRGustavo Adolfo Rico-Llanos
Gustavo Adolfo Rico-Llanos
JPJose M. Perez-Pomares
Jose M. Perez-Pomares
JGJuan Antonio Guadix
Juan Antonio Guadix
The presence of cartilage tissue in the embryonic and adult hearts of different vertebrate species is a well-recorded fact. However, while the embryonic neural crest has been historically considered as the main source of cardiac cartilage, recently reported results on the wide connective potential of epicardial lineage cells suggest they could also differentiate into chondrocytes. In this work, we describe the formation of cardiac cartilage clusters from proepicardial cells, both in vivo and in vitro. Our findings report, for the first time, cartilage formation from epicardial progenitor cells, and strongly support the concept of proepicardial cells as multipotent connective progenitors. These results are relevant to our understanding of cardiac cell complexity and the responses of cardiac connective tissues to pathologic stimuli.

13 January 2026 in Scientific Data
Verified
Journal Article
Open access
PDF file
SHSilvia C. Hernández
Silvia C. Hernández
MAMarina Ainciburu
Marina Ainciburu
LSLaura Sudupe
Laura Sudupe
NPNuria Planell
Nuria Planell
MLMaría López-Moreno
María López-Moreno
DGDavid Gomez-Cabrero
David Gomez-Cabrero
Cardiac fibroblasts (CFs) are key mediators of heart repair following myocardial infarction (MI). A specific CF subpopulation, termed Reparative Cardiac Fibroblasts (RCFs), has been shown to orchestrate scar formation and prevent ventricular rupture after MI. However, the timing of RCF appearance and the molecular events underlying this transition remain largely undefined. Here, we present a multi-modal dataset capturing the transcriptional dynamics of CFs during the early phase post-MI. Our integrative dataset combines bulk RNA sequencing, RNAscope in situ hybridization, and spatial transcriptomics to anatomically and temporally map the gene expression changes associated with the transition into RCFs. The dataset provides resources to characterize the distinct molecular programs that guide the emergence of RCFs from Periostin ( Postn ) + activated CFs. This dataset provides a valuable resource for investigating CF heterogeneity and reparative pathways following MI. All raw and processed data, along with detailed metadata and annotations, are made available to facilitate reuse by the cardiovascular and single-cell biology communities.

30 May 2022 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
CPC. Pogontke
C. Pogontke
JGJ. A. Guadix
J. A. Guadix
ASA. M. Sánchez-Tévar
A. M. Sánchez-Tévar
RMR. Muñoz-Chápuli
R. Muñoz-Chápuli
ARAdrián Ruiz-Villalba
Adrián Ruiz-Villalba
JPJose M. Perez-Pomares
Jose M. Perez-Pomares
Background: The cardiac interstitial cellular fraction is composed of multiple cell types. Some of these cells are known to express some well-known stem cell markers such as c-Kit and Sca1, but they are no longer accepted to be true cardiac stem cells. Although their existence in the cardiac interstitium has not been disputed, their dynamic throughout development, specific embryonic origin, and potential heterogeneity remain unknown. In this study, we hypothesized that both c-KitPOS and Sca1POS cardiac interstitial cell (CIC) subpopulations are related to the Wilms’ tumor 1 (Wt1) epicardial lineage.Methods: In this study, we have used genetic cell lineage tracing methods, immunohistochemistry, and FACS techniques to characterize cardiac c-KitPOS and Sca1POS cells.Results: Our data show that approximately 50% of cardiac c-KitPOS cells are derived from the Wt1-lineage at E15.5. This subpopulation decreased along with embryonic development, disappearing from P7 onwards. We found that a large proportion of cardiac c-KitPOS cells express specific markers strongly suggesting they are blood-borne cells. On the contrary, the percentage of Sca1POS cells within the Wt1-lineage increases postnatally. In accordance with these findings, 90% of adult epicardial-derived endothelial cells and 60% of mEFSK4POS cardiac fibroblasts expressed Sca1.Conclusion: Our study revealed a minor contribution of the Wt1-epicardial lineage to c-KitPOS CIC from embryonic stages to adulthood. Remarkably, a major part of the adult epicardial-derived cell fraction is enriched in Sca1, suggesting that this subpopulation of CICs is heterogeneous from their embryonic origin. The study of this heterogeneity can be instrumental to the development of diagnostic and prognostic tests for the evaluation of cardiac homeostasis and cardiac interstitium response to pathologic stimuli.

17 December 2025 in npj Regenerative Medicine
Verified
Journal Article
Open access
ARAdrián Ruiz-Villalba
Adrián Ruiz-Villalba
APAna Pardo-Saganta
Ana Pardo-Saganta
Fibrosis, a maladaptive response characterized by excessive extracellular matrix deposition, disrupts tissue architecture and organ function. Recent advances reveal fibroblast heterogeneity across organs, with shared Postn+ activated fibroblast subsets driving fibrogenesis. Emerging evidence links fibrosis to mechanical stress, metabolic rewiring, and non-coding RNA regulation, unveiling novel therapeutic targets. Innovative models and regenerative strategies - including senolytics, metabolic modulation, and in vivo reprogramming – hold promise to reverse fibrosis and promote tissue repair.